Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.

Association of developmental venous anomalies with perfusion abnormalities on arterial spin labeling and bolus perfusion-weighted imaging.

Iv M, Fischbein NJ, Zaharchuk G.

J Neuroimaging. 2015 Mar-Apr;25(2):243-250. doi: 10.1111/jon.12119. Epub 2014 Apr 9.

PMID:
24717021
3.

MR evaluation of developmental venous anomalies: medullary venous anatomy of venous angiomas.

Lee C, Pennington MA, Kenney CM 3rd.

AJNR Am J Neuroradiol. 1996 Jan;17(1):61-70.

4.

[Diagnostic imaging of hemangiomas in the brain].

Toyoda K, Oba H.

Brain Nerve. 2011 Jan;63(1):5-15. Review. Japanese.

PMID:
21228443
5.

Parenchymal hypointense foci associated with developmental venous anomalies: evaluation by phase-sensitive MR Imaging at 3T.

Takasugi M, Fujii S, Shinohara Y, Kaminou T, Watanabe T, Ogawa T.

AJNR Am J Neuroradiol. 2013 Oct;34(10):1940-4. doi: 10.3174/ajnr.A3495. Epub 2013 Apr 18.

6.

Flow compensated quantitative susceptibility mapping for venous oxygenation imaging.

Xu B, Liu T, Spincemaille P, Prince M, Wang Y.

Magn Reson Med. 2014 Aug;72(2):438-45. doi: 10.1002/mrm.24937. Epub 2013 Sep 4.

7.

Brain parenchymal signal abnormalities associated with developmental venous anomalies: detailed MR imaging assessment.

Santucci GM, Leach JL, Ying J, Leach SD, Tomsick TA.

AJNR Am J Neuroradiol. 2008 Aug;29(7):1317-23. doi: 10.3174/ajnr.A1090. Epub 2008 Apr 16.

8.

Magnetic resonance imaging findings of developmental venous anomalies.

Gökçe E, Acu B, Beyhan M, Celikyay F, Celikyay R.

Clin Neuroradiol. 2014 Jun;24(2):135-43. doi: 10.1007/s00062-013-0235-9. Epub 2013 Nov 17.

PMID:
24240482
9.

Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping: Relationship with pallidal T1 hyperintensity.

Lee S, Nam Y, Jang J, Na GH, Kim DG, Shin NY, Choi HS, Jung SL, Ahn KJ, Kim BS.

J Magn Reson Imaging. 2018 May;47(5):1342-1349. doi: 10.1002/jmri.25841. Epub 2017 Aug 17.

PMID:
28815906
10.

An interleaved sequence for simultaneous magnetic resonance angiography (MRA), susceptibility weighted imaging (SWI) and quantitative susceptibility mapping (QSM).

Chen Y, Liu S, Buch S, Hu J, Kang Y, Haacke EM.

Magn Reson Imaging. 2018 Apr;47:1-6. doi: 10.1016/j.mri.2017.11.005. Epub 2017 Nov 14.

PMID:
29154893
11.

Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.

Doganay S, Gumus K, Koc G, Bayram AK, Dogan MS, Arslan D, Gumus H, Gorkem SB, Ciraci S, Serin HI, Coskun A.

Magn Reson Med Sci. 2018 Jan 10;17(1):73-79. doi: 10.2463/mrms.mp.2016-0145. Epub 2017 May 18.

12.

Developmental Venous Anomaly: Benign or Not Benign.

Aoki R, Srivatanakul K.

Neurol Med Chir (Tokyo). 2016 Sep 15;56(9):534-43. doi: 10.2176/nmc.ra.2016-0030. Epub 2016 Jun 1. Review.

13.

STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.

Chen Y, Liu S, Wang Y, Kang Y, Haacke EM.

Magn Reson Imaging. 2018 Feb;46:130-139. doi: 10.1016/j.mri.2017.10.005. Epub 2017 Oct 19.

PMID:
29056394
14.

Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase.

Hsieh MC, Kuo LW, Huang YA, Chen JH.

Magn Reson Med. 2017 Feb;77(2):592-602. doi: 10.1002/mrm.26139. Epub 2016 Feb 1.

PMID:
26834053
15.
16.

Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping.

Liu T, Surapaneni K, Lou M, Cheng L, Spincemaille P, Wang Y.

Radiology. 2012 Jan;262(1):269-78. doi: 10.1148/radiol.11110251. Epub 2011 Nov 4.

17.

Pediatric holohemispheric developmental venous anomaly: definitive characterization by 3D susceptibility weighted magnetic resonance angiography.

Casey MA, Lahoti S, Gordhan A.

J Radiol Case Rep. 2011;5(5):10-8. doi: 10.3941/jrcr.v5i5.769. Epub 2011 May 1.

18.

Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration.

Zeng J, Xing W, Liao W, Wang X.

J Clin Neurosci. 2019 Jan;59:20-28. doi: 10.1016/j.jocn.2018.10.090. Epub 2018 Nov 2.

19.

Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.

Chawla S, Kister I, Wuerfel J, Brisset JC, Liu S, Sinnecker T, Dusek P, Haacke EM, Paul F, Ge Y.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1223-30. doi: 10.3174/ajnr.A4729. Epub 2016 Mar 24.

20.

Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.

Tan H, Liu T, Wu Y, Thacker J, Shenkar R, Mikati AG, Shi C, Dykstra C, Wang Y, Prasad PV, Edelman RR, Awad IA.

Invest Radiol. 2014 Jul;49(7):498-504. doi: 10.1097/RLI.0000000000000043.

Supplemental Content

Support Center